line

Innovative Science
Affordable Medicine

We are growing every moment to be the best in global competition

WELLMARKERBIO

WellMarkerBio Co., Ltd. is the first spin off company from Asan Medical Center
developing patient-oriented anticancer drug based on precision medicine.

Wellmarkerbio Co., Ltd is developing new anticancer drug based on a predictive biomarker.
Our company aims to provide optimized treatments to patients with medical
unmet needs through innovative R&D.

Learn More

Core Development Technology

What is a Biomarker?
line

An indicator that can predict whether
the anticancer drug is effective before administering the
drug is called a “Biomarker”.Our company is mainly developing
a “Predictive Biomarker” which can show a change
in a patient’s body after delivering the drug.

What is an Optimal pathway?
line

An optimal pathway is WMBIO’s innovative methodology
used for new drug development through biomarker analysis
for the patient’s samples.By using this predictive biomarker, not only can
we develop patient specific treatments and raise the success rate of
developing new drugs but we can lower the development cost.

COMPANY

Address

(05855) 7F, 155
Songpadae-ro Songpa-gu, Seoul, Korea

CONTACT US

Tel.

+82-2-6952-1631

Fax.

+82-2-6952-1648

E-mail.

bjy6820@wmbio.co

This post is also available in: Korean